HUP0100580A2 - Oldott paroxetint tartalmazó készítmények - Google Patents

Oldott paroxetint tartalmazó készítmények

Info

Publication number
HUP0100580A2
HUP0100580A2 HU0100580A HUP0100580A HUP0100580A2 HU P0100580 A2 HUP0100580 A2 HU P0100580A2 HU 0100580 A HU0100580 A HU 0100580A HU P0100580 A HUP0100580 A HU P0100580A HU P0100580 A2 HUP0100580 A2 HU P0100580A2
Authority
HU
Hungary
Prior art keywords
paroxetine
solid
hemihydrate
subject matter
solutions
Prior art date
Application number
HU0100580A
Other languages
English (en)
Inventor
Ahmad Ghazawi
Graham Stanley Leonard
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of HUP0100580A2 publication Critical patent/HUP0100580A2/hu
Publication of HUP0100580A3 publication Critical patent/HUP0100580A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A tal lm ny olyan, paroxetint tartalmazó gyógyszerkészítményekrevonatkozik, amelyekben a paroxetin egy szil rd, félszil rd vagyfolyékony hordozóval alkotott oldat form j ban van jelen. Az oldatokkapszul kba t"lthetők, illetve az "nhordozó szil rd oldatok szil rddózisform kk , péld ul tablett kk vagy pelletekké alakíthatók. A tal lm ny t rgy t képezik az olyan, új, folyékony készítményekis, amelyekben a paroxetin olajokban és/vagy lipidekben t"rténő oldóds hoz szolubiliz ló szereket alkalmaznak. A tal lm ny t rgy t képeziktov bb olyan elj r sok is, amelyekben a paroxetin hemihidr ttól eltérőm s form inak a hemihidr tt t"rténő talakul s t megakad lyozandó,vízmentes vagy hidrofób hordozókat vagy vivőanyagokat alkalmaznak. Ó
HU0100580A 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine HUP0100580A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation
PCT/GB1998/003471 WO1999026625A1 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine

Publications (2)

Publication Number Publication Date
HUP0100580A2 true HUP0100580A2 (hu) 2002-04-29
HUP0100580A3 HUP0100580A3 (en) 2002-05-28

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100580A HUP0100580A3 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine

Country Status (24)

Country Link
EP (1) EP1033986A1 (hu)
JP (1) JP2001523718A (hu)
KR (1) KR20010032320A (hu)
CN (1) CN1279608A (hu)
AP (1) AP2000001821A0 (hu)
AR (1) AR015485A1 (hu)
AU (1) AU1168099A (hu)
BG (1) BG104527A (hu)
BR (1) BR9814220A (hu)
CO (1) CO4970832A1 (hu)
DZ (1) DZ2658A1 (hu)
EA (1) EA200000552A1 (hu)
GB (1) GB9724544D0 (hu)
HU (1) HUP0100580A3 (hu)
IL (1) IL136106A0 (hu)
MA (1) MA24704A1 (hu)
NO (1) NO20002590L (hu)
OA (1) OA11385A (hu)
PE (1) PE20000381A1 (hu)
PL (1) PL340555A1 (hu)
SK (1) SK7342000A3 (hu)
TR (1) TR200001423T2 (hu)
WO (1) WO1999026625A1 (hu)
ZA (1) ZA9810637B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
JP4854115B2 (ja) * 1999-03-12 2012-01-18 エイシカ ファーマシューティカルス リミテッド 無水パロキセチン用安定製剤形
ES2206254T3 (es) 1999-07-01 2004-05-16 Italfarmaco S.P.A. Complejos de paroxetina con ciclodextrinas o derivados de ciclodextrinas.
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
DE60222803T2 (de) * 2001-12-21 2008-07-17 Supernus Pharmaceuticals, Inc. Orale kapselformulierung mit verbesserter physikalischer stabilität
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
US20120322752A1 (en) * 2009-12-08 2012-12-20 Sung Kyun Lee SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3768536B2 (ja) * 1995-04-03 2006-04-19 アボツト・ラボラトリーズ 低温溶融性薬物と制御放出のための添加物との均質混合物
EA002034B1 (ru) * 1997-01-15 2001-12-24 Смитклайн Бичам Плс Композиция на основе пароксетина

Also Published As

Publication number Publication date
WO1999026625A1 (en) 1999-06-03
DZ2658A1 (fr) 2003-03-22
AU1168099A (en) 1999-06-15
OA11385A (en) 2004-01-27
EA200000552A1 (ru) 2000-10-30
CN1279608A (zh) 2001-01-10
PE20000381A1 (es) 2000-05-07
GB9724544D0 (en) 1998-01-21
AR015485A1 (es) 2001-05-02
CO4970832A1 (es) 2000-11-07
NO20002590D0 (no) 2000-05-19
NO20002590L (no) 2000-07-19
KR20010032320A (ko) 2001-04-16
HUP0100580A3 (en) 2002-05-28
SK7342000A3 (en) 2000-12-11
TR200001423T2 (tr) 2000-10-23
BG104527A (en) 2001-04-30
AP2000001821A0 (en) 2000-06-30
EP1033986A1 (en) 2000-09-13
JP2001523718A (ja) 2001-11-27
ZA9810637B (en) 2000-05-22
MA24704A1 (fr) 1999-07-01
BR9814220A (pt) 2001-12-26
IL136106A0 (en) 2001-05-20
PL340555A1 (en) 2001-02-12

Similar Documents

Publication Publication Date Title
ATE429210T1 (de) Orale flüssige zusammensetzungen
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
ES2191862T3 (es) Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
HUP0100580A2 (hu) Oldott paroxetint tartalmazó készítmények
HUP9701111A2 (hu) Töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
BR9906920A (pt) "tts contendo um antioxidante"
HUP0101831A2 (hu) Szulfonamidszármazékok mint aszpartil-proteáz inhibitorok prodrugjai és ezeket tartalmazó gyógyszerkészítmények
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
DK1173153T3 (da) Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
HUP0104795A2 (hu) CCR5 modulátor hatású azabicikloalkán vegyületek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
CA2168732A1 (en) Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution
TNSN98059A1 (fr) Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant.
HUP0302452A2 (hu) Prosztaglandin E1-et tartalmazó topikus gyógyászati készítmények
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ES2055775T3 (es) Nueva forma de dosificacion.
HUP0004375A2 (hu) Azelainsavat tartalmazó kompozíció
ITMI930582A1 (it) Composizione farmeceutiche ad attivita' analgesica
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
DE69706241D1 (de) Pharmazeutische Zusammensetzung zur Behandlung der Leukämie enthaltend 9-cis-Retinoinsäure-alpha-Tocopherolester
DK0853476T3 (da) Nimesulidholdigt farmaceutisk præparat til topisk anvendelse
ES2172172T3 (es) Composiciones farmaceuticas solidas para la administracion por via oral que permiten la liberacion modulada de nicorandil y su procedimiento de preparacion.
ATE257377T1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform
DE69416034D1 (de) Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen
TH18778A (th) สูตรผสมสำหรับสารทางเคมีเภสัชศาสตร์ที่ให้ทางปาก
FR2399840A1 (fr) Application de la 2-cyano-aziridine et de ses derives a l'immunostimulation